Schaeffer's Top Stock Picks for '25

Biotech Stock Boosted on Brand-New 'Buy' Rating

The share are looking to snap an eight-day losing streak

Deputy Editor
Nov 21, 2024 at 10:48 AM
facebook X logo linkedin


Biotech stock Merus NV (NASDAQ:MRUS) is up 3.4% at $44.40 at last glance, though pulling back a bit from its premarket surge, after Goldman Sachs initiated coverage with a "buy" rating. The firm cited potential growth from the company's cancer treatment. 

Today's pop has MRUS looking to snap an eight-day losing streak. The stock dropped below long-term support at the 200-day moving average during this most recent pullback, which ended today at $42. This level also coincides with MRUS' pre-bull gap level in April. Year to date, the equity is up 58.3%. 

Analysts are wholeheartedly bullish on Merus stock, with all 17 in coverage carrying a "buy" or better rating. Plus, the 12-month consensus price target of $86.60 is a 98.4% premium to current levels. 

Options traders have been optimistic as well. MRUS' 50-day call/put volume ratio of 6.88 at the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) ranks in the 93rd percentile of its annual range. 

 
 

You have the chance to join one of Bernie's most exclusive programs, complete access at HUGE savings!

As we prepare for a new administration to take the reins in Washington, the near-term market landscape is rife with uncertainty.

The Federal Reserve has already hinted at the turbulence ahead, lowering its interest rate outlook for 2025.

Meanwhile, breakthroughs in artificial intelligence (AI), quantum computing, and other transformative sectors have unlocked incredible profit potential.

But these opportunities are fleeting, and timing is everything. That's where Quick-Hit Trader comes in.

Quick-Hit Trader is designed for precision and speed, getting you in and out of the market in a flash. While other investors scramble to navigate volatile conditions, you'll have access to expertly curated trades that leverage these rapid shifts to deliver explosive profits in short order.

This is your chance to capitalize on the fast-moving market like never before. Are you ready to make your move?